Questions of pathogenesis and treatment of post-stroke spasticity
https://doi.org/10.21518/2079-701X-2016-8-63-67
Abstract
About the Authors
O. E. ZinovyevaRussian Federation
V. A. Golovacheva
Russian Federation
References
1. Francisco GE, McGuire JR. Poststroke spasticity management. Stroke, 2012, 43(1): 3132-3136.
2. Ryu J, Lee J, Lee S et al. Factors predictive of spasticity and their effects on motor recovery and functional outcomes in stroke patients. Top Stroke Rehabil, 2010, 17: 380-8.
3. O'Dwyer N. J., Ada L., Neilson P.D. Spasticity and muscle contracture following stroke. Brain, 1996, 119: 1737-1749.
4. Pantano P, Formisano R, Ricci M et al. Motor recovery after stroke. Morphological and functional brain alterations. Brain, 1996, 119: 1849-1857.
5. Sommerfeld D, Eek E, Svensson A. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke, 2004, 35: 134-9.
6. Кадыков А.С., Шахпаронова Н.В. Спастичность как проблема двигательной реабилитации: роль миорелаксантов. Неврология и ревматология, 2014, 1: 56-59.
7. Blicher JU, Jakobsen J, Andersen G et al. Cortical excitability in chronic stroke and modulation by training: a TMS study. Neurorehabil. Neural. Repair., 2009, 23: 486-493.
8. Gracies J.M. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve, 2005, 31: 535-551.
9. Lotze M, Markert J, Sauseng P et al. The role of multiple contralesional motor areas for complex hand movements after internal capsular lesion. J. Neuroscience, 2006, 26: 6096-6102.
10. Завалишин И.А., Бархатова В.П. Спастичность. Журн. неврол. и психиатрии им. С.С. Корсакова, 1997, 97(3): 68-70.
11. Клюшников С.А., Иллариошкин С.Н., Иванова-Смоленская И.А. Спастический синдром в неврологии. Возможности толперизона (Мидокалма) в терапии спастических проявлений нейроваскулярных синдромов. Атмосфера. Нервные болезни, 2009, 3: 39-44.
12. Milanov I. Clinical and neurophysiological correlations of spasticity. Funct Neurol, 1999, 14: 193-201.
13. Huang CY, Wang CH, Hwang IS. Characterization of the mechanical and neural components of spastic hypertonia with modified H reflex. J Electromyogr Kinesiol., 2006, 16: 384-391.
14. Зиновьева О.Е., Катушкина Э.А., Яхно Н.Н., и др. Изменения скелетных мышц при постинсультной спастичности. Неврологический журнал, 2011, 4: 19-26.
15. Chardon MK, Suresh NL, Rymer WZ. An evaluation of passive properties of spastic muscles in hemiparetic stroke survivors. Conf Proc IEEE Eng Med Biol Soc, 2010, 2010: 2993-2996.
16. Ситнова М.А., Есин О.Р., Ресин РГ Постинсультная боль в области плеча: патогенез, принципы лечения. Практическая медицина, 2014, 2: 53-57.
17. Matsumoto S, Kawahira K, Etoh S еt al. Short-term effects of thermotherapy for spasticity on tibial nerve F-waves in post-stroke patients. Int. J. Biometeorol., 2006, 50(4): 243-250.
18. Thrasher TA, Popovic MR. Functional electrical stimulation of walking: function, exercise and rehabilitation. Annales de readaptation et de medecine physique, 2008, 51: 452-460.
19. Fink M, Rollnik JD, Bijak M et al. Needle acupuncture in chronic poststroke leg spasticity. Arch. Phys. Med. Rehabil., 2004, 85(4): 667-672.
20. Mohammad Y, Zahra G, Hanieh M et al. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity. Iranian journal of neurology, 2013, 12(2): 47-50.
21. Simon O, Yelnik AP Managing spasticity with drugs. European journal of physiology and rehabilitation medicine, 2010, 46(3): 401-410.
22. Yazdchi M, Ghasemi Z, Moshayedi H et al. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity. Iranian journal of neurology, 2013, 12(2): 47-50.
23. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology, 1995, 45: 712-717.
24. Rashear AB, Gordon MF, Elovic E et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spastic-ity after a stroke. N. Engl. J. Med., 2002, 347: 395-400.
25. Yelnik AP, Colle FM, Bonan IV et al. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J. Neurol. Neurosurg. Psychiatry, 2007, 78: 845-848.
26. Cardoso E, Pedreira G, Prazeres A et al. Does botulinum toxin improve the function of the patient with spasticity after stroke? Arq. Neuropsiquiatr., 2007, 65(3-A): 592-595.
27. Парфенов В.А. Применение ботулинического токсина при постинсультной спастичности. Клиническая геронтология, 2001, 7(3-4): 46-49.
28. Bakheit AMO, Thilmann AF, Ward AB et al. A randomized, double-blind, placebo-controlled, dose ranging study to compare the efficacy and safety of three doses of Botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke, 2000, 31: 2402-2406.
29. Ward AB. Spasticity treatment with botulinum toxin. Turk J Med Rehab, 2007, 53(Suppl 2): 6-12.
30. Хатькова С.Е. Использование ботулотоксина (ботокс) при лечении больных с постинсультной спастичностью. Журн. неврология и психиатрия им. С.С. Корсакова, 2009, 109(6): 87-90.
31. Ward AB, Wissel J, Borg J et al. Functional goal achievement in post-stroke spasticity patients: The Botox Economic Spasticity Trial (BEST). J Rehabil Med, 2014, 46: 504-513.
32. Barnes MR. Management of spasticity. Age and Ageing, 1998, 27: 239-245.
Review
For citations:
Zinovyeva OE, Golovacheva VA. Questions of pathogenesis and treatment of post-stroke spasticity. Meditsinskiy sovet = Medical Council. 2016;(8):63-67. (In Russ.) https://doi.org/10.21518/2079-701X-2016-8-63-67